NYSE:IQV

Stock Analysis Report

Executive Summary

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.

Snowflake

Fundamentals

Moderate growth potential with imperfect balance sheet.


Similar Companies

Share Price & News

How has IQVIA Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.8%

IQV

0.7%

US Life Sciences

-0.6%

US Market


1 Year Return

22.0%

IQV

9.9%

US Life Sciences

0.6%

US Market

IQV outperformed the Life Sciences industry which returned 9.3% over the past year.

IQV outperformed the Market in United States of America which returned 1.1% over the past year.


Share holder returns

IQVIndustryMarket
7 Day2.8%0.7%-0.6%
30 Day-0.6%4.1%2.2%
90 Day-1.9%-3.2%1.1%
1 Year22.0%22.0%10.1%9.9%2.9%0.6%
3 Year95.9%95.9%76.4%75.0%44.6%35.2%
5 Year173.4%173.4%125.8%115.1%61.9%44.2%

Price Volatility Vs. Market

How volatile is IQVIA Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

1 month ago | Simply Wall St

IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

Valuation

Is IQVIA Holdings undervalued based on future cash flows and its price relative to the stock market?

125.17x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

IQVIA Holdings's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

IQVIA Holdings's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

IQVIA Holdings is overvalued based on earnings compared to the US Life Sciences industry average.

IQVIA Holdings is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

IQVIA Holdings is poor value based on expected growth next year.


Price Based on Value of Assets

IQVIA Holdings is overvalued based on assets compared to the US Life Sciences industry average.


Next Steps

Future Growth

How is IQVIA Holdings expected to perform in the next 1 to 3 years based on estimates from 18 analysts?

28.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

IQVIA Holdings's revenue is expected to grow by 7.3% yearly, however this is not considered high growth (20% yearly).

IQVIA Holdings's earnings are expected to grow significantly at over 20% yearly.

IQVIA Holdings's revenue growth is positive but not above the United States of America market average.

IQVIA Holdings's earnings growth is expected to exceed the United States of America market average.

IQVIA Holdings's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

IQVIA Holdings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has IQVIA Holdings performed over the past 5 years?

16.9%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

IQVIA Holdings's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.

IQVIA Holdings's 1-year earnings growth is negative, it can't be compared to the 5-year average.

IQVIA Holdings's 1-year earnings growth is negative, it can't be compared to the US Life Sciences industry average.


Return on Equity

IQVIA Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

IQVIA Holdings used its assets less efficiently than the US Life Sciences industry average last year based on Return on Assets.


Return on Capital Employed

IQVIA Holdings's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is IQVIA Holdings's financial position?


Financial Position Analysis

IQVIA Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

IQVIA Holdings's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

IQVIA Holdings's level of debt (168.6%) compared to net worth is high (greater than 40%).

IQVIA Holdings had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.

Debt is not well covered by operating cash flow (11.1%, less than 20% of total debt).

Interest payments on debt are not well covered by earnings (EBIT is 2x annual interest expense, ideally 3x coverage).


Balance Sheet

Low level of unsold assets.

Debt is not covered by short term assets, assets are 0.3x debt.


Next Steps

Dividend

What is IQVIA Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate IQVIA Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate IQVIA Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as IQVIA Holdings has not reported any payouts.

Unable to verify if IQVIA Holdings's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as IQVIA Holdings has not reported any payouts.


Future Payout to Shareholders

No need to calculate the sustainability of IQVIA Holdings's dividends in 3 years as they are not expected to pay a notable one for United States of America.


Next Steps

Management

What is the CEO of IQVIA Holdings's salary, the management and board of directors tenure and is there insider trading?

2.9yrs

Average management tenure


CEO

Ari Bousbib (58yo)

2.9yrs

Tenure

US$16,461,779

Compensation

Mr. Ari Bousbib serves as Chairman and Chief Executive Officer at IQVIA Holdings Inc. since October 2016 and also serves as its President. He has been the Chairman, Chief Executive Officer and President of ...


CEO Compensation Analysis

Ari's remuneration is higher than average for companies of similar size in United States of America.

Ari's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.9yrs

Average Tenure

55yo

Average Age

The tenure for the IQVIA Holdings management team is about average.


Board Age and Tenure

2.9yrs

Average Tenure

60yo

Average Age

The average tenure for the IQVIA Holdings board of directors is less than 3 years, this suggests a new board.


Insider Trading

IQVIA Holdings individual insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$284,037,62613 Aug 19
Canada Pension Plan Investment Board
EntityCompany
Shares1,810,887
Max PriceUS$156.85
SellUS$410,323,99212 Aug 19
TPG Capital, L.P.
EntityCompany
Shares2,616,028
Max PriceUS$156.85
SellUS$89,888,38212 Aug 19
Bain Capital, LP
EntityCompany
Shares573,085
Max PriceUS$156.85
SellUS$678,06305 Aug 19
Kevin Knightly
EntityIndividual
Role
Senior Key Executive
President of Information & Technology Solutions
Shares4,278
Max PriceUS$158.50
SellUS$1,100,99131 Jul 19
Kevin Knightly
EntityIndividual
Role
Senior Key Executive
President of Information & Technology Solutions
Shares6,945
Max PriceUS$158.53
SellUS$122,310,70712 Mar 19
Bain Capital, LP
EntityCompany
Shares868,684
Max PriceUS$140.80
SellUS$569,462,78412 Mar 19
TPG Capital, L.P.
EntityCompany
Shares4,044,480
Max PriceUS$140.80
SellUS$94,964,25507 Dec 18
Bain Capital, LP
EntityCompany
Shares767,574
Max PriceUS$123.72
SellUS$442,118,98706 Dec 18
TPG Capital, L.P.
EntityCompany
Shares3,573,545
Max PriceUS$123.72
SellUS$195,749,04204 Dec 18
Canada Pension Plan Investment Board
EntityCompany
Shares1,582,194
Max PriceUS$123.72

Ownership Breakdown


Management Team

  • Ari Bousbib (58yo)

    Chairman

    • Tenure: 2.9yrs
    • Compensation: US$16.46m
  • Mike McDonnell (55yo)

    Executive VP & CFO

    • Tenure: 3.8yrs
    • Compensation: US$2.57m
  • W. Staub (56yo)

    President of Research & Development Solutions

    • Tenure: 2.8yrs
    • Compensation: US$2.24m
  • Kevin Knightly (58yo)

    President of Information & Technology Solutions

    • Tenure: 2.9yrs
    • Compensation: US$2.19m
  • Eric Sherbet (55yo)

    Executive VP

    • Tenure: 1.5yrs
    • Compensation: US$1.48m
  • Manny Korakis (45yo)

    Senior VP

    • Tenure: 0.8yrs
  • Alejandro Martinez

    Chief Information Officer

    • Tenure: 4.8yrs
  • Jeff Spaeder

    Senior VP

    • Tenure: 0yrs
  • Andrew Markwick

    Vice President of Investor Relations

    • Tenure: 0yrs
  • Marla Kessler (49yo)

    Senior Vice President of Strategy

    • Tenure: 0yrs

Board Members

  • John Danhakl (63yo)

    Director

    • Tenure: 2.9yrs
  • John Connaughton (56yo)

    Director

    • Tenure: 11.7yrs
  • Ari Bousbib (58yo)

    Chairman

    • Tenure: 2.9yrs
    • Compensation: US$16.46m
  • John Leonard (62yo)

    Lead Director

    • Tenure: 1.2yrs
    • Compensation: US$325.57k
  • Mike Evanisko (69yo)

    Independent Director

    • Tenure: 9.3yrs
    • Compensation: US$309.95k
  • Jonathan Coslet (55yo)

    Director

    • Tenure: 16.7yrs
  • Ron Rittenmeyer (72yo)

    Director

    • Tenure: 2.9yrs
    • Compensation: US$334.95k
  • Colleen Goggins (65yo)

    Director

    • Tenure: 2.2yrs
    • Compensation: US$312.45k
  • Todd Sisitsky (48yo)

    Director

    • Tenure: 2.9yrs
  • James Fasano (49yo)

    Director

    • Tenure: 2.9yrs

Company Information

IQVIA Holdings Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IQVIA Holdings Inc.
  • Ticker: IQV
  • Exchange: NYSE
  • Founded: 1982
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$30.481b
  • Shares outstanding: 195.89m
  • Website: https://www.iqvia.com

Number of Employees


Location

  • IQVIA Holdings Inc.
  • 4820 Emperor Boulevard
  • Durham
  • North Carolina
  • 27703
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IQVNYSE (New York Stock Exchange)YesCommon StockUSUSDMay 2013
QTSDB (Deutsche Boerse AG)YesCommon StockDEEURMay 2013
0JDMLSE (London Stock Exchange)YesCommon StockGBUSDMay 2013
IQV *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNMay 2013

Biography

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates throug ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 00:42
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.